DUBLIN--(BUSINESS WIRE)--The "The 7th Annual Drug Repositioning, Repurposing and Rescue Conference - Student" conference has been added to ResearchAndMarkets.com's offering.
The 7th Annual Drug Repositioning, Repurposing and Rescue Conference in Chicago, is where attendees will meet and learn from the world's foremost experts in the fields of repositioning and repurposing.
Why Attend
As the Single Longest-Running Conference in the Space, this annual event continues to be the go to meeting for pharma executives, academicians, researchers and patient advocacy groups who want to keep abreast of new developments in the field, learn from experts and meet possible collaborators and partners. The agenda incorporates Case Studies, Genetics/Genomics, new Cutting-Edge Technology (including artificial intelligence), Regulatory Guidance, Big Data Approaches, New Drug Discovery Paradigms, Partnering Models, Crowdsourcing Methods and repurposing projects for Rare/Orphan Diseases, Tropical Diseases, Cancer and many other diseases and conditions.
Key Themes:
- Patient Advocacy Efforts
- New Partnerships
- Commercial Case Studies
- Collaborative Efforts
-
Systematic Repositioning And Data Analytics
Agenda:
Open Innovation - A Driver for Drug Repositioning
Repositioning is Easy - Or Is It? The impact of AI on Future Progress
Leveraging Human Genetics to Repurpose Drugs: Lessons Learned
Using Artificial Intelligence to Identify Potential Drug Repurposing Opportunities
Application of In Silico Proteome Screening to Discover a Drug's Polypharmacology to Facilitate Drug Repurposing
Nutraceuticals as Repositioning Agents: Rapid Acceleration from Bench to Clinical Trial
A Systems Biology Driven Repositioning Strategy Identifies Digoxin for Treating Groups 3 and 4 Medulloblastoma
A Systems Medicine Approach to Drug Repurposing
Systematic Drug (Re)Purposing by Triangulating Insights from Unstructured and Structured Data Using Machine Learning
Expanding the Impact of Repurposing Research
Repurposing Low-dose Methotrexate for the Treatment of Myeloproliferative Disease
Multi-orthogonal Disruptive Integration (MODI) to Teach Old Drugs New Tricks
Big Data-based Drug Repurposing Strategy
For more information about this conference visit https://www.researchandmarkets.com/research/jpg43r/the_7th_annual?w=4
